-
Subject Areas on Research
-
A multicenter trial of oral zidovudine in children with advanced human immunodeficiency virus disease. The Protocol 043 Study Group.
-
A placebo-controlled trial of ranitidine in patients with early human immunodeficiency virus infection.
-
A signature in HIV-1 envelope leader peptide associated with transition from acute to chronic infection impacts envelope processing and infectivity.
-
Allogeneic leukocytes but not therapeutic blood elements induce reactivation and dissemination of latent human immunodeficiency virus type 1 infection: implications for transfusion support of infected patients.
-
Bifunctional anti-human immunodeficiency virus type 1 small molecules with two novel mechanisms of action.
-
CD3+CD8+ cell levels as predictors of transmission in human immunodeficiency virus-infected couples: a report from the heterosexual HIV transmission study.
-
Cellular fatty acid synthase is required for late stages of HIV-1 replication.
-
Comparison of Detection Limits of Fourth- and Fifth-Generation Combination HIV Antigen-Antibody, p24 Antigen, and Viral Load Assays on Diverse HIV Isolates.
-
Comparison of human immunodeficiency virus antigens as stimulants for lymphocyte proliferation assays.
-
Cross-clade inhibition of HIV-1 replication and cytopathology by using RNase P-associated external guide sequences.
-
Direct and indirect estimates of HIV-1 incidence in a high-prevalence population.
-
Distinct genital tract HIV-specific antibody profiles associated with tenofovir gel.
-
Enhanced HIV-1 activity in bone marrow can lead to myelopoietic suppression partially contributed by gag p24.
-
Enhanced Sensitivity for Detection of HIV-1 p24 Antigen by a Novel Nuclease-Linked Fluorescence Oligonucleotide Assay.
-
Enhanced p24 antigen detection in sera from human immunodeficiency virus-infected children.
-
Genetically and epidemiologically related "non-syncytium-inducing" isolates of HIV-1 display heterogeneous growth patterns in macrophages.
-
HIV-1 sensitivity to zidovudine and clinical outcome in children.
-
Immunization with HIV Gag targeted to dendritic cells followed by recombinant New York vaccinia virus induces robust T-cell immunity in nonhuman primates.
-
Immunodominance and cross-reactivity of B5703-restricted CD8 T lymphocytes from HIV type 1 subtype C-infected Ethiopians.
-
In vitro selection and characterization of human immunodeficiency virus type 2 with decreased susceptibility to lopinavir.
-
Increased replication of non-syncytium-inducing HIV type 1 isolates in monocyte-derived macrophages is linked to advanced disease in infected children.
-
Interferon-alpha with zidovudine: safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with the acquired immunodeficiency syndrome (AIDS)
-
Kinetics of human immunodeficiency virus type 1 (HIV-1) DNA and RNA synthesis during primary HIV-1 infection.
-
Lamivudine plus zidovudine compared with zalcitabine plus zidovudine in patients with HIV infection. A randomized, double-blind, placebo-controlled trial. North American HIV Working Party.
-
Mononuclear phagocyte accumulation in visceral tissue in HIV encephalitis: evidence for increased monocyte/macrophage trafficking and altered differentiation.
-
Mucosal and systemic anti-HIV responses in rhesus macaques following combinations of intranasal and parenteral immunizations.
-
Nuclear export of late HIV-1 mRNAs occurs via a cellular protein export pathway.
-
Presence of diverse human immunodeficiency virus type 1 viral variants in Cameroon.
-
Productive human immunodeficiency virus type 1 (HIV-1) infection of nonproliferating human monocytes.
-
Rapid clearance of virus after acute HIV-1 infection: correlates of risk of AIDS.
-
Renal epithelial cells produce and spread HIV-1 via T-cell contact.
-
Safety and immunogenicity of a live recombinant canarypox virus expressing HIV type 1 gp120 MN MN tm/gag/protease LAI (ALVAC-HIV, vCP205) followed by a p24E-V3 MN synthetic peptide (CLTB-36) administered in healthy volunteers at low risk for HIV infection. AGIS Group and L'Agence Nationale de Recherches sur Le Sida.
-
Safety of autologous, ex vivo-expanded human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte infusion in HIV-infected patients.
-
Suksdorfin: an anti-HIV principle from Lomatium suksdorfii, its structure-activity correlation with related coumarins, and synergistic effects with anti-AIDS nucleosides.
-
The effect of AZT on in vitro lymphokine-activated killer (LAK) activity in human immunodeficiency virus type-1 (HIV-1) infected individuals.
-
Transfer of HIV-1-specific cytotoxic T lymphocytes to an AIDS patient leads to selection for mutant HIV variants and subsequent disease progression.
-
Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases.
-
Zidovudine, didanosine, or both as the initial treatment for symptomatic HIV-infected children. AIDS Clinical Trials Group (ACTG) Study 152 Team.